Effect of Carbonic Anhydrase IX inhibitors on human endothelial cell survival
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 159, 104964
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The critical role of Akt in cardiovascular functionVascular Pharmacology, 2015
- Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studiesBioorganic & Medicinal Chemistry, 2015
- Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer MetastasisJournal of Medicinal Chemistry, 2011
- pH control mechanisms of tumor survival and growthJournal of Cellular Physiology, 2010
- How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?Cell Cycle, 2009
- Transcription and splicing regulation in human umbilical vein endothelial cells under hypoxic stress conditions by exon arrayBMC Genomics, 2009
- VEGF as a Key Mediator of Angiogenesis in CancerOncology, 2005
- Expression of Hypoxia-Inducible Cell-Surface Transmembrane Carbonic Anhydrases in Human CancerThe American Journal of Pathology, 2001
- Bioisosterism: A Rational Approach in Drug DesignChemical Reviews, 1996
- p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.Genes & Development, 1995